Header Logo

David Cimbaluk

Concepts (151)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Diseases
3
2019
102
0.610
Why?
Kidney Neoplasms
3
2015
66
0.560
Why?
Podocytes
4
2023
41
0.540
Why?
Carcinoma, Renal Cell
2
2015
40
0.470
Why?
Biopsy, Fine-Needle
7
2013
57
0.440
Why?
Glomerulonephritis, IGA
1
2011
9
0.390
Why?
Carcinoma, Papillary
1
2010
17
0.360
Why?
Lymphatic Metastasis
3
2010
80
0.350
Why?
Tumor Virus Infections
1
2009
14
0.340
Why?
Polyomavirus Infections
1
2009
23
0.330
Why?
Adenoma
2
2021
43
0.290
Why?
Carcinosarcoma
1
2006
3
0.280
Why?
Uterine Neoplasms
1
2006
10
0.280
Why?
Pleural Neoplasms
1
2006
10
0.260
Why?
Mesothelioma
1
2006
11
0.260
Why?
Liver Neoplasms
2
2011
91
0.260
Why?
Enterocolitis
1
2005
3
0.260
Why?
Candidiasis
1
2005
19
0.260
Why?
Carcinoma, Lobular
1
2005
18
0.250
Why?
Carcinoma, Ductal, Breast
1
2005
28
0.250
Why?
Immunocompromised Host
1
2005
43
0.250
Why?
Colonoscopy
2
2021
41
0.250
Why?
Humans
23
2023
26286
0.240
Why?
Cerebral Hemorrhage
1
2005
108
0.230
Why?
Receptors, Urokinase Plasminogen Activator
2
2023
21
0.220
Why?
Breast Neoplasms
2
2015
354
0.220
Why?
Proteinuria
2
2023
57
0.210
Why?
Neoplasms, Multiple Primary
2
2015
36
0.210
Why?
Coloring Agents
1
2021
12
0.190
Why?
Mice
6
2023
1290
0.190
Why?
Antibodies
1
2021
41
0.190
Why?
Female
12
2019
14539
0.180
Why?
Inducible T-Cell Co-Stimulator Ligand
1
2019
6
0.160
Why?
Paraproteinemias
1
2019
7
0.160
Why?
Integrin alphaVbeta3
1
2019
15
0.160
Why?
Middle Aged
9
2015
8601
0.160
Why?
Adult
5
2015
7448
0.150
Why?
Animals
6
2023
3538
0.150
Why?
CD11b Antigen
1
2017
12
0.140
Why?
Toll-Like Receptors
1
2017
17
0.140
Why?
Kidney Failure, Chronic
1
2019
151
0.140
Why?
Receptor, ErbB-4
1
2016
2
0.140
Why?
Receptor, Notch1
1
2016
6
0.140
Why?
Diabetes Mellitus, Experimental
1
2016
19
0.140
Why?
Diabetic Nephropathies
1
2016
22
0.140
Why?
MicroRNAs
1
2016
42
0.130
Why?
Macrophages
1
2017
105
0.130
Why?
Receptor, ErbB-2
2
2006
47
0.130
Why?
Up-Regulation
1
2016
151
0.130
Why?
Granulomatous Mastitis
1
2015
3
0.130
Why?
Angiomyolipoma
1
2015
3
0.120
Why?
Biopsy
3
2021
200
0.120
Why?
Retrospective Studies
5
2019
3367
0.120
Why?
Lupus Erythematosus, Systemic
1
2017
191
0.110
Why?
Lung Neoplasms
3
2011
507
0.110
Why?
Male
7
2017
14162
0.110
Why?
Wilms Tumor
1
2013
10
0.110
Why?
Urologic Neoplasms
1
2011
4
0.090
Why?
Carcinoma, Transitional Cell
1
2011
14
0.090
Why?
Rhabdomyosarcoma
1
2010
7
0.090
Why?
Trisomy
1
2010
3
0.090
Why?
Bone Neoplasms
2
2011
117
0.090
Why?
Chromosomes, Human, Pair 17
1
2010
6
0.090
Why?
DNA, Neoplasm
1
2010
16
0.090
Why?
In Situ Hybridization, Fluorescence
1
2010
29
0.090
Why?
Nephrectomy
1
2010
30
0.090
Why?
Cytodiagnosis
2
2010
19
0.090
Why?
Disease-Free Survival
1
2010
159
0.090
Why?
Adenocarcinoma
1
2011
123
0.090
Why?
BK Virus
1
2009
11
0.080
Why?
Soft Tissue Neoplasms
1
2010
56
0.080
Why?
Carcinoma, Squamous Cell
1
2011
160
0.080
Why?
Fatal Outcome
2
2006
52
0.080
Why?
Chondroma
1
2008
5
0.080
Why?
Biomarkers, Tumor
1
2010
179
0.080
Why?
Kidney Transplantation
1
2009
120
0.070
Why?
Chondrocytes
1
2008
148
0.070
Why?
Mice, Knockout
2
2019
268
0.070
Why?
Tissue Array Analysis
1
2006
7
0.070
Why?
Reed-Sternberg Cells
1
2006
2
0.070
Why?
Proto-Oncogene Proteins c-kit
1
2006
14
0.070
Why?
Cyclooxygenase 2
1
2006
27
0.070
Why?
Bronchi
1
2006
11
0.070
Why?
Carcinoma, Large Cell
1
2006
12
0.070
Why?
Hodgkin Disease
1
2006
16
0.070
Why?
ErbB Receptors
1
2006
51
0.070
Why?
Vascular Endothelial Growth Factor A
1
2006
66
0.070
Why?
Arteriovenous Malformations
1
2006
3
0.070
Why?
Gastric Mucosa
1
2006
10
0.070
Why?
Stomach
1
2006
13
0.070
Why?
Arteries
1
2006
13
0.070
Why?
Gastrointestinal Hemorrhage
1
2006
16
0.070
Why?
Immunohistochemistry
1
2006
338
0.060
Why?
Receptors, Progesterone
1
2005
23
0.060
Why?
Cadherins
1
2005
34
0.060
Why?
Signal Transduction
2
2019
409
0.060
Why?
Neoplasm Staging
1
2006
314
0.060
Why?
Receptors, Estrogen
1
2005
58
0.060
Why?
Aged
4
2015
8765
0.060
Why?
Integrins
1
2023
12
0.060
Why?
Aged, 80 and over
2
2015
4675
0.050
Why?
Treatment Outcome
1
2010
3391
0.050
Why?
Staining and Labeling
1
2021
15
0.050
Why?
Tomography, X-Ray Computed
1
2005
723
0.050
Why?
Fluorescent Antibody Technique
1
2021
55
0.050
Why?
Observer Variation
1
2021
93
0.050
Why?
Diagnosis, Differential
2
2013
347
0.050
Why?
Receptor, PAR-2
1
2019
3
0.040
Why?
Protein Domains
1
2019
7
0.040
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
3
0.040
Why?
Adipocytes
1
2019
12
0.040
Why?
Amino Acid Motifs
1
2019
15
0.040
Why?
Protein Multimerization
1
2019
16
0.040
Why?
Kidney Function Tests
1
2019
22
0.040
Why?
Protein Isoforms
1
2019
46
0.040
Why?
Microscopy, Electron
1
2019
65
0.040
Why?
Immunoglobulin A
1
2019
14
0.040
Why?
HEK293 Cells
1
2019
58
0.040
Why?
Mice, Inbred BALB C
1
2019
97
0.040
Why?
Symptom Assessment
1
2019
22
0.040
Why?
Glomerular Filtration Rate
1
2019
51
0.040
Why?
Reproducibility of Results
1
2021
679
0.040
Why?
Mice, Transgenic
1
2019
201
0.040
Why?
Combined Modality Therapy
1
2019
281
0.040
Why?
Disease Management
1
2019
109
0.040
Why?
Mice, Inbred MRL lpr
1
2017
2
0.040
Why?
Interferon Regulatory Factor-3
1
2017
2
0.040
Why?
Interferon Regulatory Factor-7
1
2017
3
0.040
Why?
Forkhead Box Protein O3
1
2017
5
0.040
Why?
Interferon Type I
1
2017
11
0.040
Why?
Ribonucleases
1
2016
7
0.040
Why?
Erlotinib Hydrochloride
1
2016
10
0.030
Why?
Transforming Growth Factor beta1
1
2016
20
0.030
Why?
Chemokine CCL2
1
2016
17
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2017
49
0.030
Why?
Disease Models, Animal
1
2019
574
0.030
Why?
Polymorphism, Single Nucleotide
1
2017
272
0.030
Why?
Biomarkers
1
2019
556
0.030
Why?
Ultrasonography, Mammary
1
2015
10
0.030
Why?
Tuberous Sclerosis
1
2015
15
0.030
Why?
Severity of Illness Index
1
2019
936
0.030
Why?
Mammography
1
2015
47
0.030
Why?
Incidence
1
2015
716
0.030
Why?
Adrenal Gland Neoplasms
1
2011
9
0.020
Why?
Radiography
1
2013
616
0.020
Why?
Risk Factors
1
2016
2265
0.020
Why?
Chondroblastoma
1
2008
2
0.020
Why?
Histocytological Preparation Techniques
1
2008
3
0.020
Why?
Fibroma
1
2008
4
0.020
Why?
Chondrosarcoma
1
2008
32
0.020
Why?
Adolescent
1
2006
2080
0.010
Why?
Cimbaluk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (151)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_